Development Level

Tbio 60 | 11,445
Tdark 9 | 6,588
Tchem 6 | 1,598
Tclin 1 | 613

IMPC Phenotype

abnormal behavior 4 | 298
preweaning lethality, complete... 4 | 979
increased circulating alkaline... 3 | 122
abnormal bone structure 2 | 187
abnormal heart morphology 2 | 162
abnormal retina morphology 2 | 71
abnormal sleep behavior 2 | 70
decreased body weight 2 | 161
decreased caudal vertebrae num... 2 | 53
decreased circulating HDL chol... 2 | 68
decreased circulating choleste... 2 | 93
decreased circulating fructosa... 2 | 30
decreased circulating serum al... 2 | 82
embryonic lethality prior to o... 2 | 239
embryonic lethality prior to t... 2 | 278
enlarged heart 2 | 210
increased circulating chloride... 2 | 41
increased heart weight 2 | 62
preweaning lethality, incomple... 2 | 499
abnormal QT variability 1 | 10
abnormal allantois morphology 1 | 8
abnormal behavioral response t... 1 | 66
abnormal chorioallantoic fusio... 1 | 8
abnormal coat appearance 1 | 31
abnormal cranium morphology 1 | 36
abnormal embryo size 1 | 220
abnormal embryo turning 1 | 31
abnormal eye morphology 1 | 68
abnormal response to new envir... 1 | 10
abnormal retinal inner nuclear... 1 | 8
abnormal skin morphology 1 | 50
abnormal stomach morphology 1 | 10
abnormal vertebrae morphology 1 | 18
abnormal vibrissa morphology 1 | 25
absent startle reflex 1 | 24
anophthalmia 1 | 33
corneal opacity 1 | 32
decreased blood urea nitrogen ... 1 | 51
decreased circulating LDL chol... 1 | 38
decreased circulating alanine ... 1 | 47
decreased circulating amylase ... 1 | 28
decreased circulating aspartat... 1 | 34
decreased circulating calcium ... 1 | 36
decreased circulating creatini... 1 | 39
decreased circulating free fat... 1 | 31
decreased circulating glucose ... 1 | 126
decreased circulating iron lev... 1 | 32
decreased circulating total pr... 1 | 49
decreased eosinophil cell numb... 1 | 24
decreased grip strength 1 | 116
decreased heart left ventricle... 1 | 28
decreased lymphocyte cell numb... 1 | 83
decreased mean corpuscular vol... 1 | 79
decreased mean platelet volume 1 | 25
decreased spleen weight 1 | 10
decreased startle reflex 1 | 75
decreased total body fat amoun... 1 | 207
decreased total retina thickne... 1 | 17
decreased vertical activity 1 | 208
enlarged kidney 1 | 14
hyperactivity 1 | 148
hypoactivity 1 | 132
increased anxiety-related resp... 1 | 2
increased body temperature 1 | 9
increased body weight 1 | 25
increased bone mineral content 1 | 108
increased circulating calcium ... 1 | 34
increased circulating creatini... 1 | 38
increased circulating iron lev... 1 | 30
increased circulating phosphat... 1 | 26
increased circulating serum al... 1 | 22
increased circulating total pr... 1 | 28
increased heart rate 1 | 23
increased lean body mass 1 | 172
increased mean corpuscular hem... 1 | 96
increased mean corpuscular vol... 1 | 92
increased neutrophil cell numb... 1 | 46
increased or absent threshold ... 1 | 101
increased prepulse inhibition 1 | 32
increased red blood cell distr... 1 | 34
increased spleen weight 1 | 10
increased startle reflex 1 | 112
increased total body fat amoun... 1 | 134
pallor 1 | 34
prenatal lethality prior to he... 1 | 87
prolonged QT interval 1 | 38
prolonged ST segment 1 | 36
short tibia 1 | 97
shortened PQ interval 1 | 7
shortened PR interval 1 | 6
shortened ST segment 1 | 10
thin ventricular wall 1 | 24
thrombocytosis 1 | 27

Disease

Carcinoma 51 | 11,493
ovarian cancer 39 | 8,520
glioblastoma 38 | 5,792
osteosarcoma 35 | 7,950
psoriasis 35 | 6,694
medulloblastoma, large-cell 33 | 6,241
atypical teratoid / rhabdoid tumor 27 | 5,112
ependymoma 27 | 4,679
intraductal papillary-mucinous adenoma (IPMA) 25 | 2,955
lung cancer 25 | 4,740
intraductal papillary-mucinous neoplasm (IPMN) 24 | 3,291
intraductal papillary-mucinous carcinoma (IPMC) 21 | 2,989
oligodendroglioma 21 | 2,850
lung carcinoma 20 | 2,843
adult high grade glioma 19 | 3,801
group 3 medulloblastoma 19 | 4,104
lung adenocarcinoma 18 | 2,716
Astrocytoma, Pilocytic 17 | 3,081
non-small cell lung cancer 17 | 2,890
Breast cancer 16 | 3,578
astrocytic glioma 16 | 2,597
pancreatic cancer 16 | 2,398
subependymal giant cell astrocytoma 16 | 2,287
primitive neuroectodermal tumor 15 | 3,035
invasive ductal carcinoma 14 | 2,951
malignant mesothelioma 14 | 3,232
pituitary cancer 14 | 1,972
Cancer 13 | 2,499
Kidney cancer 13 | 2,613
group 4 medulloblastoma 13 | 1,855
Autosomal recessive predisposition 11 | 1,442
acute quadriplegic myopathy 11 | 1,158
breast carcinoma 11 | 1,638
interstitial cystitis 10 | 2,312
pancreatic ductal adenocarcinoma liver metastasis 10 | 1,962
ductal carcinoma in situ 9 | 1,745
spina bifida 9 | 1,074
Liver Cirrhosis, Experimental 8 | 769
Multiple myeloma 8 | 1,332
colon cancer 8 | 1,478
pediatric high grade glioma 8 | 1,064
primary pancreatic ductal adenocarcinoma 8 | 1,109
ulcerative colitis 8 | 1,819
Duchenne muscular dystrophy 7 | 601
Schizophrenia 7 | 1,160
tuberculosis 7 | 2,010
Bipolar Disorder 6 | 666
Intellectual disability 6 | 1,016
Pick disease 6 | 1,894
adrenocortical carcinoma 6 | 1,428
cutaneous lupus erythematosus 6 | 1,057
cystic fibrosis 6 | 1,696
diabetes mellitus 6 | 1,728
juvenile dermatomyositis 6 | 1,187
primary Sjogren syndrome 6 | 735
Breast Neoplasms 5 | 445
Distal arthrogryposis 5 | 42
Proteinuria 5 | 144
acute myeloid leukemia 5 | 783
aldosterone-producing adenoma 5 | 665
astrocytoma 5 | 1,146
dermatomyositis 5 | 966
gastric cancer 5 | 459
gastric carcinoma 5 | 807
tuberculosis and treatment for 6 months 5 | 409
Alzheimer's disease 4 | 658
Cardiomyopathy, Dilated 4 | 83
Hypertension 4 | 396
Hypertensive disease 4 | 292
Hypertrophic Cardiomyopathy 4 | 117
Mammary Neoplasms 4 | 425
Muscle hypotonia 4 | 571
Obesity 4 | 678
Recurrent respiratory infections 4 | 141
Rheumatoid arthritis 4 | 1,191
Short neck 4 | 140
Short stature 4 | 531
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | 510
pancreatic carcinoma 4 | 562
Acquired scoliosis 3 | 281
Amyotrophic lateral sclerosis 3 | 451
Anteverted nostril 3 | 191
Becker muscular dystrophy 3 | 191
Curvature of spine 3 | 282
Dilated cardiomyopathy 3 | 56
Endometrial cancer 3 | 311
Kidney disease 3 | 430
Long philtrum 3 | 137
Melanoma 3 | 711
Myopathy 3 | 185
Neoplasm Invasiveness 3 | 161
Prostatic Neoplasms 3 | 495
Skin cancer 3 | 469
Waldenstrons macroglobulinemia 3 | 765
active ulcerative colitis 3 | 764
hepatocellular carcinoma 3 | 547
limb girdle muscular dystrophy 2A 3 | 213
medulloblastoma 3 | 720
periodontitis 3 | 293
posterior fossa group A ependymoma 3 | 468

Tissue

Endocrine System 76 | 18,159
Female tissues 76 | 17,400
Digestive Tract 75 | 17,369
Blood and immune system 74 | 16,909
Male tissues 74 | 17,142
Skin and soft tissues 74 | 17,230
Urinary Tract 74 | 16,678
Liver and Pancreas 73 | 16,750
Respiratory system 72 | 16,393
Cardiovascular System 71 | 15,192
Nervous System 71 | 16,725

Target Family

Non-IDG 63 | 12,091
Enzyme 11 | 4,145
Ion Channel 1 | 344
Kinase 1 | 634

GO Process

actin filament organization 76 | 76
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Myomesin-1 MYOM1 Tbio Non-IDG -1.21420 16.8 127
CD2-associated protein CD2AP Tbio Non-IDG -3.44533 2735.9 82
Leiomodin-3 LMOD3 Tbio Non-IDG -1.00928 10.3 27
SH3 domain-binding protein 1 SH3BP1 Tbio Non-IDG 0.00000 168
Transient receptor potential cation channel subfamily V member 4 TRPV4 Tchem Ion Channel -2.86016 747.3 258
Epithelial membrane protein 2 EMP2 Tbio Non-IDG -2.30856 210.6 116
Immunoglobulin superfamily member 22 IGSF22 Tdark Non-IDG 0.48 0.33 16
Thymosin beta-10 TMSB10 Tbio Non-IDG -2.17282 149.8 81
Thymosin beta-15B TMSB15B Tdark Non-IDG -0.96314 17.3 9
Thymosin beta-15A TMSB15B Tdark Non-IDG -0.96314 17.3 40